Business Context and Reporting Period
This Form 8-K filing by Globus Medical, Inc. reports a significant change in executive leadership effective August 29, 2017. The report was filed on August 28, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance changes.
Material Changes
- CEO Transition: David C. Paul resigned as Chief Executive Officer and was appointed Executive Chairman.
- New CEO Appointment: David M. Demski was appointed Chief Executive Officer, reporting to Mr. Paul.
- Effective Date: Both changes became effective on August 29, 2017.
Management Commentary and Background
David M. Demski, 59, has been a director since the company's inception in 2003. His prior roles at Globus Medical include President, Emerging Technologies (2015–2017), President and Chief Operating Officer (2008–2015), and Chief Financial Officer (2003–2008). Before joining Globus, he founded Cornerstone Capital LBO Fund and held executive roles at Gilo Ventures, Rendall and Associates, and Domino's Pizza. The Board confirmed there are no undisclosed arrangements regarding Mr. Demski's appointment.
Investor Verification Checklist
- Verify the terms of David C. Paul's compensation as Executive Chairman.
- Review the attached press release (Exhibit 99.1) for strategic rationale behind the leadership change.
- Confirm the transition timeline and reporting structure between the new CEO and Executive Chairman.